STOCK TITAN
  1. Home
  2. Sec-filings
  3. GMED
  4. [Form 4] GLOBUS MEDICAL INC Insider Trading Activity

Globus Medical (GMED) director exercises options for 25,000 new shares

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Globus Medical director Ann D. Rhoads exercised stock options to acquire 25,000 shares of Class A Common Stock at $26.27 per share. These options were granted on January 30, 2017 and were fully vested at exercise. Following the transaction, she directly owns 40,384 shares, and this filing shows no related share sales.

Positive

  • None.

Negative

  • None.
Insider RHOADS ANN D
Role null
Type Security Shares Price Value
Exercise Stock Option (Right to Buy Class A Common Stock) 25,000 $0.00 --
Exercise Class A Common Stock 25,000 $26.27 $657K
Holdings After Transaction: Stock Option (Right to Buy Class A Common Stock) — 0 shares (Direct, null); Class A Common Stock — 40,384 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options exercised 25,000 shares Class A Common Stock acquired via option exercise on June 4, 2026
Exercise price $26.27 per share Strike price for 25,000 exercised stock options
Shares owned after 40,384 shares Direct Class A Common Stock holdings following the transaction
Option grant date January 30, 2017 Grant date of fully vested options exercised
Option expiration January 30, 2027 Expiration date of exercised stock options
Stock Option (Right to Buy Class A Common Stock) financial
"security_title: "Stock Option (Right to Buy Class A Common Stock)""
Class A Common Stock financial
"security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
fully vested financial
"These options were granted on January 30, 2017 and are fully vested."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RHOADS ANN D
(Last)(First)(Middle)
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
(Street)
AUDUBON PENNSYLVANIA 19403
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [ GMED ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/04/2026M25,000A$26.2740,384D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)$26.2706/04/2026M25,000 (1)01/30/2027Class A Common Stock25,000$00D
Explanation of Responses:
1. These options were granted on January 30, 2017 and are fully vested.
/s/ Kelly G. Huller, Attorney-in-Fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Globus Medical (GMED) director Ann D. Rhoads report?

Ann D. Rhoads reported exercising stock options to acquire 25,000 shares of Globus Medical Class A Common Stock at $26.27 per share. This increased her direct holdings to 40,384 shares and involved no disclosed share sales in this filing.

Did the Globus Medical (GMED) director sell any shares in this Form 4 filing?

The filing shows no share sales by Ann D. Rhoads. She exercised options to receive 25,000 shares of Class A Common Stock and ended with 40,384 directly owned shares, indicating an exercise-and-hold transaction in this report.

What was the exercise price of the Globus Medical (GMED) stock options in this Form 4?

The stock options were exercised at $26.27 per share into 25,000 shares of Class A Common Stock. These options were originally granted on January 30, 2017 and were fully vested at the time of exercise according to the filing footnote.

How many Globus Medical (GMED) shares does Ann D. Rhoads own after this transaction?

After exercising options, Ann D. Rhoads directly owns 40,384 shares of Globus Medical Class A Common Stock. This total reflects the addition of 25,000 newly acquired shares from the option exercise reported in the Form 4 filing.

What does the Form 4 say about the vesting of the Globus Medical (GMED) options?

The Form 4 footnote explains the options were granted on January 30, 2017 and are fully vested. This means all 25,000 options were exercisable, allowing conversion into 25,000 shares of Class A Common Stock at the $26.27 strike price.